NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

The answer is that nobody knows because the MHRA cannot comment on a pending application and NWBO who certainly can comment, refuses to do so.
That being said, the phase 3 trial was flawed in my opinion, and the supposed results/efficacy are in question, otherwise a decision would already have been rendered.
It's not Big Pharma because DCVax is used only as an addition to current standard of care and would not affect current treatments being also used.
My opinion, and the opinion of many scientists is that a new confirmatory trial will be required.
Who knows, just my opinion. GL.